Starving cancer cells to enhances DNA damage and immunotherapy response release_cuop27tshzfmrpitwqkf3fxgyu

by Aashirwad Shahi, Dawit Kidane

Published in OncoTarget by Impact Journals, LLC.

2024   Volume 15, Issue 1, p392-399

Abstract

Prostate cancer (PCa) poses significant challenges in treatment, particularly when it progresses to a metastatic, castrate-resistant state. Conventional therapies, including chemotherapy, radiotherapy, and hormonal treatments, often fail due to toxicities, off-target effects, and acquired resistance. This research perspective defines an alternative therapeutic strategy focusing on the metabolic vulnerabilities of PCa cells, specifically their reliance on non-essential amino acids such as cysteine. Using an engineered enzyme cyst(e)inase to deplete the cysteine/cystine can induce oxidative stress and DNA damage in cancer cells. This depletion elevates reactive oxygen species (ROS) levels, disrupts glutathione synthesis, and enhances DNA damage, leading to cancer cell death. The combinatorial use of cyst(e)inase with agents targeting antioxidant defenses, such as thioredoxins, further amplifies ROS accumulation and cytotoxicity in PCa cells. Overall, in this perspective provides a compressive overview of the previous work on manipulating amino acid metabolism and redox balance modulate the efficacy of DNA repair-targeted and immune checkpoint blockade therapies in prostate cancer.
In text/plain format

Archived Files and Locations

application/pdf   1.2 MB
file_eu63bliudfcjpio6nossupitou
www.oncotarget.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2024-06-20
Language   en ?
Container Metadata
Open Access Publication
Not in DOAJ
In ISSN ROAD
Not in Keepers Registry
ISSN-L:  1949-2553
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f64215c3-9793-4ebe-9eb9-ce1116af62f6
API URL: JSON